One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1136/jitc-2022-005301
Copy DOI Journal: Journal for ImmunoTherapy of Cancer |  Publication Date: Mar 1, 2023 |
 Citations: 16 |  License type: open-access |
Affiliation: GlaxoSmithKline (United States), Dana-Farber Cancer Institute, Research Triangle Park Foundation, The University of Texas MD Anderson Cancer Center, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Sarah Cannon, MSD (United States), Memorial Sloan Kettering Cancer Center, New York University Langone Medical Center, Institut Gustave Roussy, Institut Polytechnique de Paris, University of Paris-Saclay, Princess Margaret Cancer Centre, New York Medical CollegeBackgroundThe phase I first-in-human study ENGAGE-1 evaluated the humanized IgG1 OX40 agonistic monoclonal antibody GSK3174998 alone (Part 1 (P1)) or in combination with pembrolizumab (Part 2 (P2)) in patients with...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
